Phibro Animal Health Corporation (NASDAQ:PAHC) VP Daniel M. Bendheim sold 4,976 shares of the stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $40.01, for a total transaction of $199,089.76. Following the transaction, the vice president now owns 4,176 shares in the company, valued at $167,081.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) traded down 0.25% on Tuesday, hitting $39.50. 56,263 shares of the stock traded hands. The firm has a market cap of $1.57 billion, a PE ratio of 24.53 and a beta of 1.35. Phibro Animal Health Corporation has a 52-week low of $20.14 and a 52-week high of $40.25. The firm has a 50 day moving average price of $38.43 and a 200 day moving average price of $32.86.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 27th. Investors of record on Wednesday, September 6th will be given a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a yield of 1.01%. The ex-dividend date is Friday, September 1st. Phibro Animal Health Corporation’s dividend payout ratio (DPR) is currently 24.69%.
TRADEMARK VIOLATION NOTICE: “Insider Selling: Phibro Animal Health Corporation (PAHC) VP Sells 4,976 Shares of Stock” was posted by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece on another website, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The correct version of this piece can be read at https://stocknewstimes.com/2017/08/22/insider-selling-phibro-animal-health-corporation-pahc-vp-sells-4976-shares-of-stock.html.
A number of research analysts have commented on PAHC shares. Zacks Investment Research upgraded shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a research report on Thursday, May 11th. Piper Jaffray Companies set a $35.00 price target on shares of Phibro Animal Health Corporation and gave the company a “buy” rating in a research report on Friday, July 21st. BidaskClub cut shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, June 14th. Finally, Credit Suisse Group cut shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and increased their price target for the company from $29.00 to $36.00 in a research report on Friday, June 2nd. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. Phibro Animal Health Corporation currently has an average rating of “Hold” and an average target price of $30.50.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Trexquant Investment LP boosted its stake in shares of Phibro Animal Health Corporation by 4.9% in the first quarter. Trexquant Investment LP now owns 27,402 shares of the company’s stock worth $770,000 after buying an additional 1,288 shares in the last quarter. Morgan Stanley boosted its stake in shares of Phibro Animal Health Corporation by 1.7% in the first quarter. Morgan Stanley now owns 172,773 shares of the company’s stock worth $4,855,000 after buying an additional 2,868 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of Phibro Animal Health Corporation by 8.2% in the first quarter. Vanguard Group Inc. now owns 1,729,406 shares of the company’s stock worth $48,597,000 after buying an additional 130,935 shares in the last quarter. Arizona State Retirement System boosted its stake in shares of Phibro Animal Health Corporation by 2.1% in the first quarter. Arizona State Retirement System now owns 9,700 shares of the company’s stock worth $273,000 after buying an additional 200 shares in the last quarter. Finally, Tudor Investment Corp ET AL boosted its stake in shares of Phibro Animal Health Corporation by 66.2% in the first quarter. Tudor Investment Corp ET AL now owns 16,171 shares of the company’s stock worth $454,000 after buying an additional 6,444 shares in the last quarter. 47.64% of the stock is owned by institutional investors and hedge funds.
Phibro Animal Health Corporation Company Profile
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
